Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Agomelatine is marketed for the treatment of major depressive disorder and has been reported to not produce discontinuation syndrome and have no sexual side effects compared to SSRIs
InChi: InChI=1S/C44H49N13O7/c1-26-32-23-47-44(50-39(32)56(29-6-3-4-7-29)42(62)37(26)27(2)58)48-35-12-10-30(22-46-35)54-17-15-53(16-18-54)24-28-25-55(52-51-28)19-21-64-20-14-45-33-9-5-8-31-38(33)43(63)57(41(31)61)34-11-13-36(59)49-40(34)60/h5
CAS Number: 1253186-49-0
Formula: C29H30F6N4O
Formula: C21H20F6N2O3
GDC-0994 Catalog No.:M8781-10 Agomelatine is marketed for theRavoxertinib also known as GDC 0994 and RG7842, is an orally available inhibitor of extracellular signal regulated kinase (ERK), with potential antineoplastic activity. Upon oral administration, GDC 0994 inhibits both ERK phosphorylation and activation of ERK mediated signal transduction pathways. This prevents ERK dependent tumor cell proliferation and survival. The mitogen activated protein kinase (MAPK) ERK pathway is upregulated in a variety of
US$ 38.50
US$ 35.00